Volsaa 500mg Tablet CR

Описание товара

About Volsaa 500mg Tablet CR

Volsaa 500mg Tablet CR is a prescription medication that delivers a controlled release of sodium valproate, an anticonvulsant used to manage seizure disorders. Each tablet contains 500 milligrams of the active ingredient, formulated to maintain therapeutic blood levels over an extended period. The controlled‑release design helps reduce the frequency of dosing while providing consistent seizure control. This medication is typically prescribed for patients with partial seizures, generalized tonic‑clonic seizures, or other seizure types as determined by a qualified healthcare professional. Patients should follow their prescriber’s instructions and attend regular follow‑up appointments to monitor efficacy and safety.

Key Benefits & Uses

• Provides sustained seizure control with a single daily dose.
• Reduces the need for multiple daily administrations.
• Supports consistent therapeutic drug levels for better seizure management.

Active Ingredient & Action

The active ingredient, sodium valproate, works by increasing gamma‑aminobutyric acid (GABA) levels in the brain, which helps stabilize neuronal activity and prevent the spread of seizure activity. By maintaining a steady concentration of the drug, the controlled‑release formulation enhances seizure suppression while minimizing peaks and troughs that can cause side effects.

Important Notes

Volsaa 500mg Tablet CR is a prescription medication and should only be taken under the supervision of a qualified healthcare provider. Patients should inform their doctor of any other medications they are taking, as drug interactions can occur. Regular monitoring of liver function and blood counts is recommended, especially during the initial months of therapy. If you experience any unusual symptoms, such as severe abdominal pain, jaundice, or changes in mood, contact your healthcare provider promptly. This medication should not be used by individuals with known hypersensitivity to sodium valproate or related compounds.